Author Question: When supervisors support diversity, subordinates are more likely to be committed to it. Indicate ... (Read 57 times)

robinn137

  • Hero Member
  • *****
  • Posts: 544
When supervisors support diversity, subordinates are more likely to be committed to it.
 
  Indicate whether the statement is true or false

Question 2

Define organizational commitment, and identify and describe its forms.
 
  What will be an ideal response?



Heffejeff

  • Sr. Member
  • ****
  • Posts: 336
Answer to Question 1

TRUE

Answer to Question 2

Organizational commitment is the degree to which people feel psychological attachment toward their organizations, feel involved, and are interested in remaining with them. Continuance commitment is the desire to remain with an organization because of beliefs about the costs of leaving. Affective commitment is the desire to remain with the organization because of liking it or an attraction to it. Normative commitment is a feeling of obligation to remain with an organization because of pressure from others.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

In Eastern Europe and Russia, interferon is administered intranasally in varied doses for the common cold and influenza. It is claimed that this treatment can lower the risk of infection by as much as 60–70%.

Did you know?

In ancient Rome, many of the richer people in the population had lead-induced gout. The reason for this is unclear. Lead poisoning has also been linked to madness.

Did you know?

Though Candida and Aspergillus species are the most common fungal pathogens causing invasive fungal disease in the immunocompromised, infections due to previously uncommon hyaline and dematiaceous filamentous fungi are occurring more often today. Rare fungal infections, once accurately diagnosed, may require surgical debridement, immunotherapy, and newer antifungals used singly or in combination with older antifungals, on a case-by-case basis.

Did you know?

Aspirin may benefit 11 different cancers, including those of the colon, pancreas, lungs, prostate, breasts, and leukemia.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library